J Korean Soc Radiol.  2012 Jan;66(1):47-50. 10.3348/jksr.2012.66.1.47.

Primary Signet-Ring Carcinoma in the Bladder Presenting as a Hypervascular Luminal Polypoid Mass

Affiliations
  • 1Department of Radiology, Eulji Hospital, Eulji University College of Medicine, Seoul, Korea. a0302@hanmail.net
  • 2Department of Pathology, Eulji Hospital, Eulji University College of Medicine, Seoul, Korea.
  • 3Department of Urology, Eulji Hospital, Eulji University College of Medicine, Seoul, Korea.

Abstract

Primary signet-ring carcinoma is a very aggressive and rare variant of a primary urinary bladder cancer, accounting for less than 1% of cases. We reported on a 76-year-old patient with primary signet-ring carcinoma who occurred metastatic lymphadenopathy with extranodal invasion causing intraluminal tumor thrombi in the adjacent vein, and pulmonary metastasis over the course of three months. We demonstrated the computed tomography findings of primary signet-ring carcinoma of the bladder and correlated the imaging findings with the pathologic features. We reviewed the distinguishing imaging findings of the primary signet-ring carcinoma compared with urothelial cell carcinoma, the most common subtype of the bladder cancer.


MeSH Terms

Accounting
Adenocarcinoma
Aged
Humans
Lymphatic Diseases
Neoplasm Metastasis
Phenobarbital
Thromboembolism
Urinary Bladder
Urinary Bladder Neoplasms
Veins
Phenobarbital

Reference

1. Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics. 2006. 26:553–580.
2. Hughes MJ, Fisher C, Sohaib SA. Imaging features of primary nonurachal adenocarcinoma of the bladder. AJR Am J Roentgenol. 2004. 183:1397–1401.
3. Michels J, Barbour S, Cavers D, Chi KN. Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature. Can Urol Assoc J. 2010. 4:E55–E57.
4. Busto Martín LA, Janeiro Pais M, González Dacal J, Chantada Abal V, Busto Castañón L. Signet-ring cell adenocarcinoma of the bladder: case series between 1990-2009. Arch Esp Urol. 2010. 63:150–153.
5. Shanks JH, Iczkowski KA. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics. Histopathology. 2009. 54:885–900.
6. Abol-Enein H, Kava BR, Carmack AJ. Nonurothelial cancer of the bladder. Urology. 2007. 69:93–104.
7. Kundra V, Silverman PM. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder. AJR Am J Roentgenol. 2003. 180:1045–1054.
8. Anderström C, Johansson SL, von Schultz L. Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study. Cancer. 1983. 52:1273–1280.
9. Fischer CG, Waechter W, Kraus S, Fuentecilla Perez E, Weidner W, Dudeck J. Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registries. Cancer. 1998. 82:775–783.
Full Text Links
  • JKSR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr